You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Blinatumomab

Showing 26 - 50 of 101
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ALL, Recurrent, Adult Trial in Frankfurt (Main), Kiel (Blinatumomab, Venetoclax)

Recruiting
  • ALL, Recurrent, Adult
  • Frankfurt (Main), Hessen, Germany
  • +1 more
Jan 6, 2022

B-cell Adult Acute Lymphoblastic Leukemia, Stem Cell Leukemia, Minimal Residual Disease Trial in Vancouver, Halifax

Terminated
  • B-cell Adult Acute Lymphoblastic Leukemia
  • +2 more
  • blinatumomab
  • Vancouver, British Columbia, Canada
  • +2 more
Feb 3, 2022

Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial (Blinatumomab)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • Mixed Phenotype Acute Leukemia
  • Blinatumomab
  • (no location specified)
Apr 7, 2022

Relapsed/Refractory Philadelphia Positive B-precursor ALL Trial in Worldwide (Blinatumomab)

Completed
Has Results
  • Relapsed/Refractory Philadelphia Positive B-precursor ALL
  • Blinatumomab
  • Duarte, California
  • +21 more
Sep 8, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +7 more
  • Blinatumomab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

ALL, Recurrent, Adult Trial in Germany (Blinatumomab)

Active, not recruiting
  • ALL, Recurrent, Adult
  • Blinatumomab
  • Frankfurt (Main), Hessen, Germany
  • +21 more
Mar 16, 2022

Richter Syndrome Trial in France (RCHOP, Blinatumomab)

Active, not recruiting
  • Richter Syndrome
  • Amiens, France
  • +27 more
Jul 26, 2022

Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia Trial in Bergamo (Blinatumomab Expanded T-cells (BET))

Active, not recruiting
  • Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia
  • Blinatumomab Expanded T-cells (BET)
  • Bergamo, Italy
    ASST - Papa Giovanni XXIII
Dec 22, 2021

Recurrent B Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia, Refractory B Acute Lymphoblastic Leukemia

Recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +3 more
  • Blinatumomab
  • +2 more
  • New Haven, Connecticut
  • +6 more
Jul 9, 2022

Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL Trial in Spain (blinatumomab)

Terminated
  • Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL
  • blinatumomab
  • Badalona, Barcelona, Spain
  • +11 more
Jul 26, 2022

Acute Lymphoblastic Leukemia Trial in Worldwide (Blinatumomab, AMG 404, Dexamethasone Premedication)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Blinatumomab
  • +2 more
  • Duarte, California
  • +18 more
Jul 27, 2022

B-cell Acute Lymphoblastic Leukemia Trial in Tampa, Durham, Winston-Salem (Blinatumomab)

Withdrawn
  • B-cell Acute Lymphoblastic Leukemia
  • Blinatumomab
  • Tampa, Florida
  • +2 more
Feb 14, 2022

ALL, Adult Trial in Belgium, Netherlands (Blinatumomab)

Active, not recruiting
  • ALL, Adult
  • Blinatumomab
  • Antwerpen, Belgium
  • +17 more
Dec 29, 2021

B-cell Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, B-Cell ALL, Childhood Trial in Milwaukee

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Alpha/Beta T-cell and B-cell depleted HCT
  • Blinatumomab
  • Milwaukee, Wisconsin
    Children's Hospital of Wisconsin
Sep 12, 2021

Acute Lymphoid Leukemia Trial in Seoul (Blincyto)

Not yet recruiting
  • Acute Lymphoid Leukemia
  • Seoul, Gangnam-gu, Korea, Republic of
  • +4 more
Apr 12, 2023

Acute Lymphoblastic Leukemia, Adult B-Cell Trial in Paris (Blinatumomab Injection)

Active, not recruiting
  • Acute Lymphoblastic Leukemia, Adult B-Cell
  • Blinatumomab Injection
  • Paris, France
    Hopital saint Louis
Apr 30, 2021

Adult Philadelphia Chromosome-Positive Acute Lymphoblastic

Recruiting
  • Acute Lymphoblastic Leukemia
  • Dasatinib and blinatumomab
  • Bari, Italy
  • +16 more
Oct 10, 2022

Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)

Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • +7 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 8, 2021

Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), ALL, Adult, Philadelphia-Positive ALL Trial in Italy (Ponatinib

Recruiting
  • Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
  • +2 more
  • Ponatinib + Blinatumomab
  • Chemotherapy + Imatinib
  • Ascoli Piceno, Italy
  • +14 more
Jan 3, 2022

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)

Not yet recruiting
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 23, 2022

Philadelphia-Negative ALL, High-Risk Cancer Trial in Israel (Blinatumomab)

Recruiting
  • Philadelphia-Negative ALL
  • High-Risk Cancer
  • Blinatumomab
  • Haifa, Israel
  • +3 more
May 6, 2021

Non-Hodgkin Lymphoma Trial in Boston (Blinatumomab)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Blinatumomab
  • Boston, Massachusetts
    Massachusetts general Hospital
Jan 31, 2021

B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Nov 8, 2023

Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia Trial in

Terminated
Has Results
  • Philadelphia Chromosome Negative
  • +2 more
  • Blinatumomab
  • +11 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 3, 2022

Leukemia, B-cell, Lymphoma, B-Cell Trial in Cincinnati (Blinatumomab, Pembrolizumab)

Withdrawn
  • Leukemia, B-cell
  • Lymphoma, B-Cell
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Mar 30, 2021